Puig Leaps on Potential Estee Lauder Merger
The stock surged after the company and Estee Lauder confirmed they were in talks over a possible merger, which would combine two of the world's biggest beauty companies.
----
Apollo to Acquire Nippon Sheet Glass in $3.7 Billion Deal
The deal is Apollo Global Management's largest private-equity investment in Japan to date.
----
Xiaomi Quarterly Profit Falls Amid Rising Memory Costs
Xiaomi reported a slump in quarterly net profit, caught between soaring memory-chip prices and subdued consumption in one of the world's largest consumer markets.
----
SK Hynix to Buy $8 Billion of ASML EUV Equipment
The South Korean chip maker is ramping up its advanced-chip production capability in response to surging demand fueled by artificial intelligence.
----
Super Micro's Fate Lies in Nvidia's Hands
The troubled maker of artificial-intelligence servers needs chip allocations, but Nvidia doesn't need more scrutiny over China.
----
S4 Capital Shares Jump After Company Reassures on Outlook
The advertising company founded by industry veteran Martin Sorrell projected in-line revenue performance for 2026 and higher profitability.
----
Berkshire's New Partner Tokio Marine Dominates Japan's Insurance Industry
Tokio Marine is a top 10 non-life insurer by market value globally behind companies such as Chubb, Progressive and Allianz.
----
Europe Tesla Sales Rebound After Monthslong Slump
Tesla notched its first increase in European monthly sales in more than a year, a boost for the EV maker as it faces competition from Chinese auto giant BYD to win over customers.
----
How Nvidia Keeps Its Iron Grip on the AI Boom
The chip giant has invested tens of billions from its fast-growing war chest to become the industry's most powerful kingmaker.
----
The Chinese Billionaire Who Says America's EV Market Is Doomed Without Him
Robin Zeng of CATL can't build a factory in America, but Ford and GM rely on its technology.
----
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets
Gilead Sciences plans to acquire Ouro Medicines for up to about $2.18 billion and develop the assets from the deal in a collaboration with Galapagos.
(END) Dow Jones Newswires
March 24, 2026 07:00 ET (11:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments